GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Double Bond Pharmaceutical International AB (XSAT:DBP B) » Definitions » Market Cap

Double Bond Pharmaceutical International AB (XSAT:DBP B) Market Cap : kr11.84 Mil (As of Jun. 26, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Double Bond Pharmaceutical International AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Double Bond Pharmaceutical International AB's share price for the quarter that ended in Mar. 2025 was kr0.29. Double Bond Pharmaceutical International AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 107.12 Mil. Therefore, Double Bond Pharmaceutical International AB's market cap for the quarter that ended in Mar. 2025 was kr31.06 Mil.

Double Bond Pharmaceutical International AB's quarterly market cap declined from Sep. 2024 (kr50.24 Mil) to Dec. 2024 (kr40.38 Mil) and declined from Dec. 2024 (kr40.38 Mil) to Mar. 2025 (kr31.06 Mil).

Double Bond Pharmaceutical International AB's annual market cap increased from Dec. 2022 (kr38.36 Mil) to Dec. 2023 (kr69.23 Mil) but then declined from Dec. 2023 (kr69.23 Mil) to Dec. 2024 (kr40.38 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Double Bond Pharmaceutical International AB's Enterprise Value for Today is kr9.31 Mil.


Double Bond Pharmaceutical International AB Market Cap Historical Data

The historical data trend for Double Bond Pharmaceutical International AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Double Bond Pharmaceutical International AB Market Cap Chart

Double Bond Pharmaceutical International AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 126.44 52.31 38.36 69.23 40.38

Double Bond Pharmaceutical International AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 73.05 47.03 50.24 40.38 31.06

Competitive Comparison of Double Bond Pharmaceutical International AB's Market Cap

For the Biotechnology subindustry, Double Bond Pharmaceutical International AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Double Bond Pharmaceutical International AB's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Double Bond Pharmaceutical International AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Double Bond Pharmaceutical International AB's Market Cap falls into.


;
;

Double Bond Pharmaceutical International AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Double Bond Pharmaceutical International AB's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=kr0.377*107.120
=kr40.38

Double Bond Pharmaceutical International AB's Market Cap for the quarter that ended in Mar. 2025 is calculated as

Market Cap (Q: Mar. 2025 )=Share Price (Q: Mar. 2025 )*Shares Outstanding (EOP) (Q: Mar. 2025 )
=kr0.29*107.120
=kr31.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Double Bond Pharmaceutical International AB  (XSAT:DBP B) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Double Bond Pharmaceutical International AB Market Cap Related Terms

Thank you for viewing the detailed overview of Double Bond Pharmaceutical International AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Double Bond Pharmaceutical International AB Business Description

Traded in Other Exchanges
N/A
Address
Virdings Alle 32B, Uppsala, SWE, 75450
Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other life-threatening disorders.

Double Bond Pharmaceutical International AB Headlines

No Headlines